No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
CN Stock MarketDetailed Quotes
600829 HPGC Renmintongtai Pharmaceutical Corporation
- 8.19
- +0.11+1.36%
Market Closed Dec 20 15:00 CST
4.75BMarket Cap18.45P/E (TTM)
8.50High8.01Low332.08KlotVolume8.01Open8.08Pre Close274.18MTurnover5.73%Turnover Ratio16.25P/E (Static)579.89MShares11.2852wk High1.65P/B4.75BFloat Cap4.8252wk Low8.89Limit Up579.89MShs Float27.74Historical High7.27Limit Down6.06%Amplitude-2.21Historical Low0.14Dividend TTM8.26Avg Price154.89KlotAsk1.76%Div YieldTTM100Lot Size158.59KlotBid
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | HPGC Renmintongtai Pharmaceutical Corporation: No undisclosed major events.
Express News | HPGC Renmintongtai Pharmaceutical Corporation: There have been no significant changes in the main business.
Express News | The pharmaceutical commerce sector has surged significantly, with many stocks such as Yaoyigou hitting the limit up.
A-share pharmaceutical commerce stocks soared, hpgc renmintongtai hit the limit up.
On November 12, HPGC Renmintongtai Pharmaceutical Corporation hit the limit up, PharmEasy rose more than 10%, Guangxi Liuyao Group, SH Pharma, jointown pharmaceutical group, Shuyu Pingmin and others followed the upward trend.
Third Quarter Report 2024
hpgc renmintongtai pharmaceutical corporation (600829.SH) released its performance for the first three quarters, with a net income of 0.206 billion yuan, a year-on-year decrease of 14.36%.
hpgc renmintongtai pharmaceutical corporation (600829.SH) disclosed the third quarter report for 2024, achieving a revenue of 76...
